Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein
Identifieur interne : 001E35 ( Main/Exploration ); précédent : 001E34; suivant : 001E36Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein
Auteurs : Innocent N. Mbawuike [États-Unis] ; Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Christopher S. Jones [États-Unis] ; Thomas R. Cate [États-Unis] ; Robert B. Couch [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 1994.
Descripteurs français
- KwdFr :
- Animaux, Aérosols, Cytométrie en flux, Femelle, Infections à Orthomyxoviridae (), Lymphocytes T CD4+ (immunologie), Lymphocytes T CD8+ (immunologie), Protéines recombinantes, Protéines virales (immunologie), Réactions croisées (immunologie), Réplication virale (immunologie), Souris, Souris de lignée BALB C, Souris de lignée C57BL, Tests de cytotoxicité immunologique, Tests de neutralisation, Vaccins antigrippaux (immunologie), Vaccins synthétiques (immunologie), Virus de la grippe A (immunologie).
- MESH :
- immunologie : Lymphocytes T CD4+, Lymphocytes T CD8+, Protéines virales, Réactions croisées, Réplication virale, Vaccins antigrippaux, Vaccins synthétiques, Virus de la grippe A.
- Animaux, Aérosols, Cytométrie en flux, Femelle, Infections à Orthomyxoviridae, Protéines recombinantes, Souris, Souris de lignée BALB C, Souris de lignée C57BL, Tests de cytotoxicité immunologique, Tests de neutralisation.
English descriptors
- KwdEn :
- Aerosols, Animals, CD4-Positive T-Lymphocytes (immunology), CD8-Positive T-Lymphocytes (immunology), Chimeric influenza protein, Cross Reactions (immunology), Cytotoxicity Tests, Immunologic, Female, Flow Cytometry, Influenza A virus (immunology), Influenza Vaccines (immunology), Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Neutralization Tests, Orthomyxoviridae Infections (prevention & control), Recombinant Proteins, Vaccines, Synthetic (immunology), Viral Proteins (immunology), Virus Replication (immunology), cross-protection, influenza A subtype.
- MESH :
- chemical , immunology : Influenza Vaccines, Vaccines, Synthetic, Viral Proteins.
- immunology : CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cross Reactions, Influenza A virus, Virus Replication.
- prevention & control : Orthomyxoviridae Infections.
- Teeft :
- Active immunization, Adoptive transfer, Aerosols, Agents chemother, Alum, Amino acids, Animals, Antibody responses, Antibody treatment, Antigenic, Antigenic drift, Braciale, Cell response, Chimeric, Chimeric protein, Clone, Control mice, Cotton rats, Cumulative mortality rates, Cytotoxic, Cytotoxicity Tests, Immunologic, Effector, Effector cells, Ennis, Experiments mice, Female, Flow Cytometry, Further evaluation, Haplotype dependence, Immune, Immunization, Immunodominant epitope, Immunol, Inbred, Inbred mice, Infection, Influenza, Influenza nucleoprotein, Influenza pneumonia, Influenza vaccines, Influenza virus, Influenza virus challenge, Influenza virus infection, Influenza viruses, Last injection, Ldso, Lethal dose, Lung virus, Lung virus infection, Lymphocyte, Lymphocyte clones, Mabs, Major histocompatibility, Maximal release, Mbawuike, Mdck cells, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Microneutralization test, Mouse, Natl acad, Neutralization Tests, Neutralizing, Neutralizing activity, Neutralizing antibody, Ntab, Nucleoprotein, Outbred, Outbred mice, Outbred swiss, Passive transfer, Peptide, Present results, Present study, Previous studies, Protection rate, Protective efficacy, Protective immunity, Protein, Proteinimmunized mice, Recombinant, Recombinant Proteins, Respiratory syncytial virus, Significant protection, Spleen cells, Splenic lymphocytes, Squirrel monkeys, Stimulator cells, Subunit, Swiss mice, Syncytial virus, Synthetic peptides, Target cells, Tract infection, Unimmunized mice, Unpublished results, Vaccine, Viral, Viral clearance, Virol, Virus, Virus challenge, Virus infection, Virus infections, Virus titres, Vivo depletion.
Abstract
Influenza A/PR/8/34-derived chimeric (D) protein (SK&F 106160) composed of the first 81 amino acids (aa) of NS1 fused to the conserved 157 C-terminal aa of HA2 (NS11-81-HA 265-222) was previously shown to induce H-2d-restricted protective cytotoxic T-lymphocyte (CTL) immunity in inbred mice. However, D protein, like other small peptides, exhibited haplotype dependence and was not immunogenic in H-2b and H-2K mice. A potential use of this antigen in humans and the role of T cells in any protection were evaluated in outbred Swiss and inbred CBF6F1 (H-2d/b) mice. Mice immunized with D protein and challenged by small-particle aerosol with a lethal dose of influenza virus were significantly protected against mortality from influenza A/HINI and A/H2N2 (p < 0.05- < 0.0000001), but not from A/H3N2 and influenza B viruses when compared with control mice. D protein did not induce serum virus-neutralizing antibody but caused virus to be cleared faster in immunized mice. Protection was long-lasting. In vivo depletion of either Lyt2 (CD8+) or L3T4 (CD4+) T cells with monoclonal antibodies led to abrogation of in vitro-generated CTL activity in CF6F1 mice and significant reduction in the protective efficacy of D protein against virus challenge in both Swiss and CF6F1 mice. These results suggest that protection was mediated by CD8+ and/or CD4+ cells and not antibody. Thus D protein, via a conserved sequence on the HA2 polypeptide, has the potential to induce partially cross-reactive CTL that may protect against influenza virus disease in humans.
Url:
DOI: 10.1016/S0264-410X(94)80063-6
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000612
- to stream Istex, to step Curation: 000612
- to stream Istex, to step Checkpoint: 000C06
- to stream Main, to step Merge: 001F17
- to stream PubMed, to step Corpus: 000412
- to stream PubMed, to step Curation: 000412
- to stream PubMed, to step Checkpoint: 000379
- to stream Ncbi, to step Merge: 001300
- to stream Ncbi, to step Curation: 001300
- to stream Ncbi, to step Checkpoint: 001300
- to stream Main, to step Merge: 001E59
- to stream Main, to step Curation: 001E35
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein</title>
<author><name sortKey="Mbawuike, Innocent N" sort="Mbawuike, Innocent N" uniqKey="Mbawuike I" first="Innocent N." last="Mbawuike">Innocent N. Mbawuike</name>
</author>
<author><name sortKey="Dillon, Susan B" sort="Dillon, Susan B" uniqKey="Dillon S" first="Susan B." last="Dillon">Susan B. Dillon</name>
</author>
<author><name sortKey="Demuth, Sandra G" sort="Demuth, Sandra G" uniqKey="Demuth S" first="Sandra G." last="Demuth">Sandra G. Demuth</name>
</author>
<author><name sortKey="Jones, Christopher S" sort="Jones, Christopher S" uniqKey="Jones C" first="Christopher S." last="Jones">Christopher S. Jones</name>
</author>
<author><name sortKey="Cate, Thomas R" sort="Cate, Thomas R" uniqKey="Cate T" first="Thomas R." last="Cate">Thomas R. Cate</name>
</author>
<author><name sortKey="Couch, Robert B" sort="Couch, Robert B" uniqKey="Couch R" first="Robert B." last="Couch">Robert B. Couch</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:54C5831E113BF2DB7342E03B1398837221FC3977</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1016/S0264-410X(94)80063-6</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-2QRMW5H6-Q/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000612</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000612</idno>
<idno type="wicri:Area/Istex/Curation">000612</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C06</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C06</idno>
<idno type="wicri:doubleKey">0264-410X:1994:Mbawuike I:influenza:a:subtype</idno>
<idno type="wicri:Area/Main/Merge">001F17</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7856302</idno>
<idno type="wicri:Area/PubMed/Corpus">000412</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000412</idno>
<idno type="wicri:Area/PubMed/Curation">000412</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000412</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000379</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000379</idno>
<idno type="wicri:Area/Ncbi/Merge">001300</idno>
<idno type="wicri:Area/Ncbi/Curation">001300</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001300</idno>
<idno type="wicri:doubleKey">0264-410X:1994:Mbawuike I:influenza:a:subtype</idno>
<idno type="wicri:Area/Main/Merge">001E59</idno>
<idno type="wicri:Area/Main/Curation">001E35</idno>
<idno type="wicri:Area/Main/Exploration">001E35</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein</title>
<author><name sortKey="Mbawuike, Innocent N" sort="Mbawuike, Innocent N" uniqKey="Mbawuike I" first="Innocent N." last="Mbawuike">Innocent N. Mbawuike</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Acute Viral Respiratory Disease Unit, Influenza Research Center, Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Dillon, Susan B" sort="Dillon, Susan B" uniqKey="Dillon S" first="Susan B." last="Dillon">Susan B. Dillon</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Virology and Host Defense SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Demuth, Sandra G" sort="Demuth, Sandra G" uniqKey="Demuth S" first="Sandra G." last="Demuth">Sandra G. Demuth</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Virology and Host Defense SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jones, Christopher S" sort="Jones, Christopher S" uniqKey="Jones C" first="Christopher S." last="Jones">Christopher S. Jones</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Virology and Host Defense SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cate, Thomas R" sort="Cate, Thomas R" uniqKey="Cate T" first="Thomas R." last="Cate">Thomas R. Cate</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Acute Viral Respiratory Disease Unit, Influenza Research Center, Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Couch, Robert B" sort="Couch, Robert B" uniqKey="Couch R" first="Robert B." last="Couch">Robert B. Couch</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Acute Viral Respiratory Disease Unit, Influenza Research Center, Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1994">1994</date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">14</biblScope>
<biblScope unit="page" from="1340">1340</biblScope>
<biblScope unit="page" to="1348">1348</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aerosols</term>
<term>Animals</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Chimeric influenza protein</term>
<term>Cross Reactions (immunology)</term>
<term>Cytotoxicity Tests, Immunologic</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mice, Inbred C57BL</term>
<term>Neutralization Tests</term>
<term>Orthomyxoviridae Infections (prevention & control)</term>
<term>Recombinant Proteins</term>
<term>Vaccines, Synthetic (immunology)</term>
<term>Viral Proteins (immunology)</term>
<term>Virus Replication (immunology)</term>
<term>cross-protection</term>
<term>influenza A subtype</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Aérosols</term>
<term>Cytométrie en flux</term>
<term>Femelle</term>
<term>Infections à Orthomyxoviridae ()</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Lymphocytes T CD8+ (immunologie)</term>
<term>Protéines recombinantes</term>
<term>Protéines virales (immunologie)</term>
<term>Réactions croisées (immunologie)</term>
<term>Réplication virale (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Souris de lignée C57BL</term>
<term>Tests de cytotoxicité immunologique</term>
<term>Tests de neutralisation</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins synthétiques (immunologie)</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
<term>Vaccines, Synthetic</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T CD4+</term>
<term>Lymphocytes T CD8+</term>
<term>Protéines virales</term>
<term>Réactions croisées</term>
<term>Réplication virale</term>
<term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>CD8-Positive T-Lymphocytes</term>
<term>Cross Reactions</term>
<term>Influenza A virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Active immunization</term>
<term>Adoptive transfer</term>
<term>Aerosols</term>
<term>Agents chemother</term>
<term>Alum</term>
<term>Amino acids</term>
<term>Animals</term>
<term>Antibody responses</term>
<term>Antibody treatment</term>
<term>Antigenic</term>
<term>Antigenic drift</term>
<term>Braciale</term>
<term>Cell response</term>
<term>Chimeric</term>
<term>Chimeric protein</term>
<term>Clone</term>
<term>Control mice</term>
<term>Cotton rats</term>
<term>Cumulative mortality rates</term>
<term>Cytotoxic</term>
<term>Cytotoxicity Tests, Immunologic</term>
<term>Effector</term>
<term>Effector cells</term>
<term>Ennis</term>
<term>Experiments mice</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>Further evaluation</term>
<term>Haplotype dependence</term>
<term>Immune</term>
<term>Immunization</term>
<term>Immunodominant epitope</term>
<term>Immunol</term>
<term>Inbred</term>
<term>Inbred mice</term>
<term>Infection</term>
<term>Influenza</term>
<term>Influenza nucleoprotein</term>
<term>Influenza pneumonia</term>
<term>Influenza vaccines</term>
<term>Influenza virus</term>
<term>Influenza virus challenge</term>
<term>Influenza virus infection</term>
<term>Influenza viruses</term>
<term>Last injection</term>
<term>Ldso</term>
<term>Lethal dose</term>
<term>Lung virus</term>
<term>Lung virus infection</term>
<term>Lymphocyte</term>
<term>Lymphocyte clones</term>
<term>Mabs</term>
<term>Major histocompatibility</term>
<term>Maximal release</term>
<term>Mbawuike</term>
<term>Mdck cells</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mice, Inbred C57BL</term>
<term>Microneutralization test</term>
<term>Mouse</term>
<term>Natl acad</term>
<term>Neutralization Tests</term>
<term>Neutralizing</term>
<term>Neutralizing activity</term>
<term>Neutralizing antibody</term>
<term>Ntab</term>
<term>Nucleoprotein</term>
<term>Outbred</term>
<term>Outbred mice</term>
<term>Outbred swiss</term>
<term>Passive transfer</term>
<term>Peptide</term>
<term>Present results</term>
<term>Present study</term>
<term>Previous studies</term>
<term>Protection rate</term>
<term>Protective efficacy</term>
<term>Protective immunity</term>
<term>Protein</term>
<term>Proteinimmunized mice</term>
<term>Recombinant</term>
<term>Recombinant Proteins</term>
<term>Respiratory syncytial virus</term>
<term>Significant protection</term>
<term>Spleen cells</term>
<term>Splenic lymphocytes</term>
<term>Squirrel monkeys</term>
<term>Stimulator cells</term>
<term>Subunit</term>
<term>Swiss mice</term>
<term>Syncytial virus</term>
<term>Synthetic peptides</term>
<term>Target cells</term>
<term>Tract infection</term>
<term>Unimmunized mice</term>
<term>Unpublished results</term>
<term>Vaccine</term>
<term>Viral</term>
<term>Viral clearance</term>
<term>Virol</term>
<term>Virus</term>
<term>Virus challenge</term>
<term>Virus infection</term>
<term>Virus infections</term>
<term>Virus titres</term>
<term>Vivo depletion</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Aérosols</term>
<term>Cytométrie en flux</term>
<term>Femelle</term>
<term>Infections à Orthomyxoviridae</term>
<term>Protéines recombinantes</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Souris de lignée C57BL</term>
<term>Tests de cytotoxicité immunologique</term>
<term>Tests de neutralisation</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Influenza A/PR/8/34-derived chimeric (D) protein (SK&F 106160) composed of the first 81 amino acids (aa) of NS1 fused to the conserved 157 C-terminal aa of HA2 (NS11-81-HA 265-222) was previously shown to induce H-2d-restricted protective cytotoxic T-lymphocyte (CTL) immunity in inbred mice. However, D protein, like other small peptides, exhibited haplotype dependence and was not immunogenic in H-2b and H-2K mice. A potential use of this antigen in humans and the role of T cells in any protection were evaluated in outbred Swiss and inbred CBF6F1 (H-2d/b) mice. Mice immunized with D protein and challenged by small-particle aerosol with a lethal dose of influenza virus were significantly protected against mortality from influenza A/HINI and A/H2N2 (p < 0.05- < 0.0000001), but not from A/H3N2 and influenza B viruses when compared with control mice. D protein did not induce serum virus-neutralizing antibody but caused virus to be cleared faster in immunized mice. Protection was long-lasting. In vivo depletion of either Lyt2 (CD8+) or L3T4 (CD4+) T cells with monoclonal antibodies led to abrogation of in vitro-generated CTL activity in CF6F1 mice and significant reduction in the protective efficacy of D protein against virus challenge in both Swiss and CF6F1 mice. These results suggest that protection was mediated by CD8+ and/or CD4+ cells and not antibody. Thus D protein, via a conserved sequence on the HA2 polypeptide, has the potential to induce partially cross-reactive CTL that may protect against influenza virus disease in humans.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
<li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Mbawuike, Innocent N" sort="Mbawuike, Innocent N" uniqKey="Mbawuike I" first="Innocent N." last="Mbawuike">Innocent N. Mbawuike</name>
</region>
<name sortKey="Cate, Thomas R" sort="Cate, Thomas R" uniqKey="Cate T" first="Thomas R." last="Cate">Thomas R. Cate</name>
<name sortKey="Couch, Robert B" sort="Couch, Robert B" uniqKey="Couch R" first="Robert B." last="Couch">Robert B. Couch</name>
<name sortKey="Demuth, Sandra G" sort="Demuth, Sandra G" uniqKey="Demuth S" first="Sandra G." last="Demuth">Sandra G. Demuth</name>
<name sortKey="Dillon, Susan B" sort="Dillon, Susan B" uniqKey="Dillon S" first="Susan B." last="Dillon">Susan B. Dillon</name>
<name sortKey="Jones, Christopher S" sort="Jones, Christopher S" uniqKey="Jones C" first="Christopher S." last="Jones">Christopher S. Jones</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:54C5831E113BF2DB7342E03B1398837221FC3977 |texte= Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein }}
This area was generated with Dilib version V0.6.33. |